European Respiratory Society

Patients with severe asthma and blood eosinophil counts ≥150–<300 cells/μL showed reduced severe disease exacerbations and maintenance oral corticosteroid use with mepolizumab, whilst improving asthma control and lung function in routine clinical practice https://bit.ly/40dTdHR

ERJ Open Research: A Chatbot-guided application provided educational content incorporating GINA guidelines and direct contact with pulmonology specialists. Compared with standard therapeutic education, its use was associated with improvements in QoL. https://bit.ly/4fzXWu8

ERJ Open Research: Cough-variant asthma exhibits overlapping but distinct airway transcriptomic profiles compared to classic asthma. Two distinct inflammatory endotypes of cough-variant asthma are identified, presenting different clinical outcomes. https://bit.ly/3Zmgjvs

Asthma or allergic asthma in the mother increases the risk of asthma in the child. Higher maternal lung function in pregnancy leads to a lower risk of asthma in the child. https://bit.ly/4cTSy3n

European Respiratory Journal: FENO testing at attack can identify the patients on anti-IL5/IL5Rα biologics who have the most lung function and symptom benefits from prednisolone https://bit.ly/3KhMB68

New Interactive Education video available: Early diagnosis of ILD!

Join Prof. Elisabetta Renzoni, Prof. Sara Tomasetti, and Dr Raphael Borie as they use real-world clinical scenarios to discuss critical gaps in knowledge.

Watch now on the ERS Respiratory Channel: https://bit.ly/443ekP3

ERJ Open Research: The risk of pulmonary embolism was clinically lower in patients with purulent acute exacerbation of COPD (AECOPD) compared to patients with nonpurulent/unknown aetiology AECOPD https://bit.ly/4leYsQt

ERJ: In this pilot study in 20 adults with cystic fibrosis and iron deficiency, treatment with intravenous iron improved blood haemoglobin concentration and exercise capacity, without any adverse effect on clinical or laboratory markers of infection https://bit.ly/47eQKkR

European Respiratory Journal: Basophils play crucial roles in the acute respiratory distress syndrome resolution phase by producing IL-4 that act on neutrophils and alleviate acute lung inflammation in model mice https://bit.ly/44SJ3iz

European Respiratory Journal: Immunosuppressive macrophages contribute to the disease progression of LAM https://bit.ly/43YosJa

ERJ Open Research: It seems advisable to systematically detect and correct patient–ventilator interactions in home mechanical ventilated patients https://bit.ly/4hTsyq3

Learn more about recent scientific developments in pneumonia this #WorldPneumoniaDay with our ERS Publications collection 🦠

Access information on community-acquired pneumonia, drug-resistance, and more: https://bit.ly/49wuAvN

ERS and ELF call for urgent action to defend science and protect public health The European Respiratory Society (ERS) and the European Lung Foundation (ELF) have today issued a joint statement warning of the escalating threats to science and scientists worldwide.

With @europeanlung.bsky.social, we are calling on leaders to protect independent science, tackle disinformation and support health research.

Learn more and join us in this effort: www.ersnet.org/news-and-fea...

Defend and trust in science. Protect public health.

That is our message to European Union leaders. Watch as Joanna Chorostowska-Wynimko, ERS President, explains 💬

Eur Respir J: The impairment of IgA-related mucosal immunity after lung transplantation occurs early in the development of bronchiolitis obliterans syndrome (BOS), preceding clinical diagnosis. This suggests its potential as a predictor for BOS onset. https://bit.ly/3RVMmyp

ERJ Open Research: ETI therapy in patients with NCFB and an amenable CFTR mutation led to a significant improvement in pulmonary function, clinical status and daily symptoms, suggesting ETI may prove beneficial as an adjuvant therapy for NCFB https://bit.ly/3DVXiIQ

📖 The forthcoming ERS Monograph on “Chronic Cough” is now available to pre-order. The book will cover pathophysiology, assessment, management, treatable traits & future directions.

Pre-order before 16 Nov & receive a €10 discount: https://bit.ly/43o6YVY

ERJ Open Research: Patients who experienced CV events after COPD exacerbations received more intensive COPD treatment and had more HCRU compared with patients whose CV events occurred without COPD exacerbations in the prior 12 months https://bit.ly/4iuPxaW

🎙️ ERJ Podcast: Listen as Deputy Chief Editor Don Sin interviews Section Editor Isabella Annesi-Maesano about natural disasters and respiratory health, as discussed in Isabella’s article in the most recent edition of the ERJ.

Listen: https://channel.ersnet.org/channel-86-erj-podcast?contId=114954

ERJOR: Disease-modifying treatments in COPD are currently lacking. A novel platform for imaging inflammatory cytokine activity in airway disease may provide a new precision medicine approach to determine the most appropriate treatment for an individual. https://bit.ly/42BrJfH

ERJ Open Research: Alveolar macrophage carbon is increased in the distal airways of COPD patients compared to smokers with an inverse association with lung function. Presence of alveolar macrophage carbon alters cellular size and phenotype. https://bit.ly/43N5Zy8

“By participating we, as members, can shape the Society’s future” - Dr Ildikó Horváth, ERS Secretary General

The deadline for applications and nominations for the ERS elections 2026 is 9 November! Apply or nominate a peer online: https://www.ersnet.org/the-society/elections-and-open-positions/

We have collated a selection of #ERSCongress 2025 sessions and made them free to view exclusively on the ERS Respiratory Channel 🎥

See what’s available: https://bit.ly/49CIjko

Want more? You can still register and access all sessions until the end of the year!

ERJ Open Research: Alveolar macrophage carbon is increased in the distal airways of COPD patients compared to smokers with an inverse association with lung function. Presence of alveolar macrophage carbon alters cellular size and phenotype. https://bit.ly/43N5Zy8

The ERJ presents the latest in its series of podcasts. @donsin4 interviews Section Editor Isabella Annesi-Maesano about natural disasters and respiratory health, as discussed in her review article in ERJ. https://bit.ly/4hDovPT

ERJ Open Research: Iron-binding proteins and the microbiome in COPD https://bit.ly/4j0I4Bs

Ready to advance your career at the upcoming Respiratory Failure and Mechanical Ventilation (RFMV) Conference 2026?

Read our Q&A with Dr Rebecca D'Cruz to learn what #RFMV2026 has to offer 👉 https://bit.ly/4oCcIDG

#respiratory #respiratoryfailure #research #lunghealth #medicine

Compared to noninvasive risk stratification, haemodynamics is less age-dependent, has added prognostic value in patients aged <44 years and can be a valid treatment goal in patients with PAH aged >65 years not reaching a low-risk noninvasive assessment https://bit.ly/42Y1OAn

⚠️ #LSC2026: Abstract submission extended!

You now have one more week to submit your abstract for presentation at the 24th ERS Lung Science Conference (19–22 March, 2026 in Estoril, Portugal and online).

Submit before 23:59 CET on 10 November: channel.ersnet.org/hp-132-1-abs...

November is #Alpha1AwarenessMonth 🌍

Alpha-1 antitrypsin deficiency is a genetic condition causing damage to the lungs and/or liver. There is no cure, but some symptoms can be managed with treatment.

Read more about the latest research on this condition: https://bit.ly/3X71QC4